Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2002
11/13/2002EP1256576A1 Fused imidazolium derivatives
11/13/2002EP1256574A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
11/13/2002EP1256573A1 Process for producing stereoisomer of pyrrolidine derivative
11/13/2002EP1255752A2 Pyrrole substituted 2-indolinone protein kinase inhibitors
11/13/2002EP1255749A1 Tyrosine derivatives with anti-leukotriene activity
11/13/2002EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002EP1255741A2 2- 1H]-QUINOLONE AND 2- 1H]-QUINOXALONE INHIBITORS OF FACTOR Xa
11/13/2002EP1255740A2 Substituted arylpyrazines
11/13/2002EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002EP1255736A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
11/13/2002EP1255734A1 Isatine derivatives with neurotrophic activity
11/13/2002EP1255733A1 Farnesyl transferase inhibitors
11/13/2002EP1255537A2 Farnesyl protein transferase inhibitors for treating breast cancer
11/13/2002EP1102762B1 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
11/13/2002EP0950057B1 3-pyridyl enantiomers and their use as analgesics
11/13/2002CN1379775A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/13/2002CN1379774A Compounds
11/13/2002CN1379773A Novel isoquinoline derivatives or salts thereof
11/13/2002CN1379772A Substituted indoles for modulating NFKB activity
11/13/2002CN1379766A Benzoic acid derivatives for treatment of diabetes mellitus
11/13/2002CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002CN1379764A Benzodiazepine derivatives
11/13/2002CN1379763A Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
11/13/2002CN1379762A Beta substituted metalloprotease inhibitors
11/13/2002CN1379671A Treating sleep disorders using desloratadine
11/13/2002CN1379670A FT-raman spectroscopic measurement of omeprazole isomer ratio in composition
11/12/2002US6479666 Phenyl-keto-imidazolidine thioamide derivatives
11/12/2002US6479663 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/12/2002US6479531 Gastrin and cholecystokinin receptor ligands
11/12/2002US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002US6479518 Zwitterionic tachykinin receptor antagonists
11/12/2002US6479514 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
11/12/2002US6479513 Anticancer compound and enantiomer separation method useful for synthesizing said compound
11/12/2002US6479512 Tyrosine kinase inhibitors
11/12/2002US6479508 Viral polymerase inhibitors
11/12/2002US6479505 6-arylphenanthridines with PDE-IV inhibiting activity
11/12/2002US6479504 Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases
11/12/2002US6479494 Arylalkanoyl pyridazines
11/12/2002US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002US6479490 Treatment of diseases characterized by excess th2 cytokines and/ or an excess ige production.
11/12/2002US6479485 Benzamidine derivatives and their use as anti-coagulants
11/12/2002US6479483 3,4,6-substituted pyridine derivatives useful for treating depression and pain, resulting from inflammatory conditions, such as migraine, rheumatoid arthritis, asthma and inflamatory bowel disease; nk1 receptor antagonist
11/12/2002US6479482 Alkylamine derivatives of dihydropyridine NPY antagonists
11/12/2002US6479480 1h-indole derivatives bearing an optionally substituted phenyl moiety at the 2-position of the indole ring system and a methylene-linked heterocyclic moiety at the 3-position of the indole ring system; schizophrenia treatment
11/12/2002US6479479 Azetidine derivatives, their preparation and pharmaceutical compositions containing them
11/12/2002US6479435 Or diaryl sulfides, 1-(4-chloro-2-fluoro-5-(2-pyrimidyloxy)phenyl)-4-difluoromethy l-3-methyl-1,4-dihydro-1,2,4-triazolin-5-one for example
11/12/2002CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/12/2002CA2246839C Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
11/12/2002CA2144294C (pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments
11/12/2002CA2099591C 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3- carboxylic acid compounds useful as antibacterial agents
11/07/2002WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002WO2002088114A2 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
11/07/2002WO2002088113A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002WO2002088111A1 Novel benzylpiperidine compound
11/07/2002WO2002088110A1 Quinoline derivative having azolyl group and quinazoline derivative
11/07/2002WO2002088109A1 Crystal of 6-[4-(4-pyridylamino)phenyl]-4, 5-dihydro-3(2h)-pyridazinone hydrochloride trihydrate
11/07/2002WO2002088108A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002WO2002088101A2 Inhibitors of bace
11/07/2002WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002WO2002088093A1 Benzimidazoles that are useful in treating sexual dysfunction
11/07/2002WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002WO2002088088A1 Process for preparing 1-methyl-1,2,3,4-tetrahydroisoquinoline or a salt thereof
11/07/2002WO2002088087A1 Novel heterocyclic derivatives
11/07/2002WO2002088084A1 Heterocyclic compound derivatives and medicines
11/07/2002WO2002088071A1 20-hydroxyeicosatetraenoic acid production inhibitors
11/07/2002WO2002087587A2 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
11/07/2002WO2002087584A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002WO2002087580A1 Abc expression promoters
11/07/2002WO2002087569A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002WO2002087338A1 Liquid formulations for dermal application in treatment of parasitic insects in animals
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002WO2002044141A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
11/07/2002WO2001042243A3 Protein kinase inhibitors
11/07/2002US20020165412 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/07/2002US20020165394 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
11/07/2002US20020165393 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
11/07/2002US20020165390 Preparation of quinoline-substituted carbonate and carbamate derivatives
11/07/2002US20020165343 Growth hormone secretagogues
11/07/2002US20020165253 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors
11/07/2002US20020165252 Such as methyl-2-cyclopentyl-4-(4-fluorophenyl)-5-oxo-7,7-dimethyl-1,4,5,6,7,8 -hexahydroquinoline-3-carboxylate for treatment of arteriosclerosis and dyslipidaemias; condensation
11/07/2002US20020165251 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder
11/07/2002US20020165241 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA)
11/07/2002US20020165240 Method of treating proliferative diseases using Eg5 inhibitors
11/07/2002US20020165239 Conjugates of sodium channel blockers and methods of using the same
11/07/2002US20020165238 Such as 1-(3-carboxypyridyl-2)-4-methyl-2- phenylpiperazine dihydrate; antidepressants
11/07/2002US20020165234 Selective B3 adrenergic agonists
11/07/2002US20020165223 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders
11/07/2002US20020165219 Novel heterocycles useful in the treatment of benign prostatic hyperplasia
11/07/2002US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002CA2450018A1 Crystal of 6-[4-(4-pyridylamino)phenyl]-4, 5-dihydro-3(2h)-pyridazinone hydrochloride trihydrate
11/07/2002CA2445871A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002CA2445568A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002CA2445348A1 Novel benzylpiperidine compound
11/07/2002CA2445294A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002CA2444500A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
1 ... 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 ... 1080